Glucosamine Linked to Faster Dementia Progression in New Study
A new study from the University of Florida suggests that glucosamine, a common over-the-counter joint supplement, may accelerate cognitive decline in individuals with Alzheimer’s disease or mild cognitive impairment. Researchers found that glucosamine use is associated with a 25% higher risk of progressing to dementia and increased mortality in dementia patients. The study links this to 'hyperglycosylation,' an overactive sugar-tagging process in the brain, though it notes that observational data cannot prove causality and calls for clinical trials.
